We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+5.32%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$160M
AUM Growth
+$10.8M
Cap. Flow
+$3.5M
Cap. Flow %
2.19%
Top 10 Hldgs %
22.6%
Holding
105
New
4
Increased
38
Reduced
27
Closed
2

Sector Composition

Rank Sector Weight
1 Industrials 17.25%
2 Technology 12.95%
3 Consumer Staples 10.6%
4 Financials 10.34%
5 Healthcare 10.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WU icon
26
Western Union
WU
$2.58B
$2.63M 1.65%
147,175
+1,700
+1% +$29.5K
UPS icon
27
United Parcel Service
UPS
$89.7B
$2.62M 1.64%
23,571
+100
+0.4% +$10.6K
CVS icon
28
CVS Health
CVS
$140B
$2.54M 1.59%
26,405
-30
-0.1% -$2.64K
SPY icon
29
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$2.42M 1.51%
11,761
MCD icon
30
McDonald's
MCD
$194B
$2.38M 1.49%
25,395
-795
-3% -$74.4K
DE icon
31
Deere & Co
DE
$173B
$2.36M 1.48%
26,672
+1,150
+5% +$99.4K
ABBV icon
32
AbbVie
ABBV
$465B
$2.35M 1.48%
35,999
+70
+0.2% +$4.41K
XLU icon
33
State Street Utilities Select Sector SPDR ETF
XLU
$23.4B
$2.35M 1.47%
99,480
-280
-0.3% -$6.34K
OMC icon
34
Omnicom Group
OMC
$24.6B
$2.33M 1.46%
30,069
+1,865
+7% +$136K
CL icon
35
Colgate-Palmolive
CL
$74.2B
$2.24M 1.41%
32,440
+180
+0.6% +$12.2K
EEM icon
36
iShares MSCI Emerging Markets ETF
EEM
$28B
$2.17M 1.36%
55,309
-8,312
-13% -$338K
HYG icon
37
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$2.17M 1.36%
24,232
+821
+4% +$74.7K
CMCSK
38
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
$2.11M 1.32%
36,613
+540
+1% +$31.1K
COP icon
39
ConocoPhillips
COP
$139B
$2.08M 1.3%
30,105
+3,560
+13% +$248K
BNY
40
Bank of New York Mellon
BNY
$106B
$2.04M 1.28%
50,260
-2,740
-5% -$107K
IJR icon
41
iShares Core S&P Small-Cap ETF
IJR
$110B
$2.03M 1.27%
35,568
+2,978
+9% +$163K
STT icon
42
State Street
STT
$50.2B
$1.99M 1.25%
25,366
+555
+2% +$41.7K
VEU icon
43
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
$1.97M 1.24%
42,079
+25,124
+148% +$1.21M
VB icon
44
Vanguard Small-Cap ETF
VB
$80.2B
$1.86M 1.16%
15,920
BBH icon
45
VanEck Biotech ETF
BBH
$409M
$1.83M 1.15%
15,908
-250
-2% -$28.2K
XLE icon
46
State Street Energy Select Sector SPDR ETF
XLE
$38.3B
$1.71M 1.07%
43,272
+23,590
+120% +$981K
EFA icon
47
iShares MSCI EAFE ETF
EFA
$76.8B
$1.47M 0.92%
24,080
-3,200
-12% -$200K
ABT icon
48
Abbott
ABT
$187B
$1.44M 0.9%
31,894
+280
+0.9% +$12.2K
T icon
49
AT&T
T
$169B
$1.38M 0.86%
54,292
-1,411
-3% -$36.6K
JNJ icon
50
Johnson & Johnson
JNJ
$643B
$1.34M 0.84%
12,840
+1,500
+13% +$158K

Similar funds

Boston Research & Management's Q4 2014 Portfolio in Review

As of Q4 2014, Boston Research & Management held 105 positions worth $160M, up 7.3% from $149M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Boston Research & Management's Q4 2014 filing shows 4 new, 38 increased, 27 reduced and 2 closed positions. Its largest new stake was Potash Corp Of Saskatchewan: 30,170 shares worth $1.06M. The largest sale was The Mosaic Company, an estimated $741K.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Staples.

  • Boston Research & Management's largest Q4 2014 buy was Potash Corp Of Saskatchewan: 30,170 shares worth $1.06M.
  • Boston Research & Management added most to Vanguard FTSE All-World ex-US ETF in Q4 2014, an estimated $1.21M increase.
  • Boston Research & Management's biggest Q4 2014 reduction was The Mosaic Company, cutting an estimated $741K.
  • Boston Research & Management fully exited iShares Core MSCI Emerging Markets ETF in Q4 2014, selling an estimated $322K.
  • Boston Research & Management's ten largest holdings make up 23% of its $160M portfolio in Q4 2014.
  • Boston Research & Management opened 4 new positions and closed 2 in Q4 2014.
  • Boston Research & Management's portfolio value rose 7.3% quarter-over-quarter to $160M.

Based on Boston Research & Management's 13F filing for Q4 2014, filed 11 Feb 2015.